tradingkey.logo
tradingkey.logo
Search

Quest Diagnostics Inc

DGX
Add to Watchlist
209.880USD
0.0000.00%
Close 06/26, 16:00ETQuotes delayed by 15 min
23.30BMarket Cap
22.79P/E TTM

Quest Diagnostics Inc

209.880
0.0000.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+7.63%

1 Month

+8.19%

6 Months

+19.29%

Year to Date

+20.95%

1 Year

+18.02%

Key Figures
--Open
0.000High
0.00Volume
22.79P/E TTM
17.94P/E Dynamic
3.260Dividend TTM
1.22%Turnover Ratio
209.880Prev. Close
0.000Low
0.00Turnover
26.90P/E Static
3.16P/B
1.55%Div Yield TTM
6.62%ROA
213.50052wk High
1.36Volume Ratio
866.00MNet Profit
111.00MShares
9.2097EPS TTM
0.59Beta
14.27%ROE
164.65052wk Low
1.62%Amplitude
31.33%Gross Margin
23.30BMarket Cap
3.71Reward/Risk
1.38%Risk Rate

Key Insights

Quest Diagnostics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 221.89.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quest Diagnostics Inc's Score

Industry at a Glance

Industry Ranking
4 / 76
Overall Ranking
22 / 4566
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

34°C

Very Low
Very High
Positive

Quest Diagnostics Inc Highlights

StrengthsRisks
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 19.27% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 11.04B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.
Overvalued
The company’s latest PE is 22.79, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 110.61M shares, decreasing 2.78% quarter-over-quarter.
Held by EDGEPOINT CANADIAN PORTFOLIO
Star Investor EDGEPOINT CANADIAN PORTFOLIO holds 2.26M shares of this stock.

Analyst Rating

Based on 20 analysts
Buy
Current Rating
221.889
Target Price
+7.59%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Quest Diagnostics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Quest Diagnostics Inc Info

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Ticker SymbolDGX
CompanyQuest Diagnostics Inc
CEODavis (James E)
Websitehttps://www.questdiagnostics.com/

FAQs

What is the current price of Quest Diagnostics Inc (DGX)?

The current price of Quest Diagnostics Inc (DGX) is 209.88.

What is the symbol of Quest Diagnostics Inc?

The ticker symbol of Quest Diagnostics Inc is DGX.

What is the 52-week high of Quest Diagnostics Inc?

The 52-week high of Quest Diagnostics Inc is 213.50.

What is the 52-week low of Quest Diagnostics Inc?

The 52-week low of Quest Diagnostics Inc is 164.65.

What is the market capitalization of Quest Diagnostics Inc?

The market capitalization of Quest Diagnostics Inc is 23.30B.

Is Quest Diagnostics Inc (DGX) currently rated as Buy, Hold, or Sell?

According to analysts, Quest Diagnostics Inc (DGX) has an overall rating of Buy, with a price target of 221.89.

What is the Earnings Per Share (EPS TTM) of Quest Diagnostics Inc (DGX)?

The Earnings Per Share (EPS TTM) of Quest Diagnostics Inc (DGX) is 8.90.
KeyAI